Xin Dong

Xin Dong

Auto-generated profile, based on publicly available information

Xin Dong

Institute of Medical Intelligence, Department of Artificial Intelligence, Beijing Key Lab of Traffic Data Analysis and Mining, School of Computer Science & Technology, Beijing Jiaotong University, Beijing, 100044, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in Journal of the American Medical Informatics Association
Verified
Journal Article
Closed access
PDF file
RHRui Hua
Rui Hua
XDXin Dong
Xin Dong
YWYu Wei
Yu Wei
ZSZixin Shu
Zixin Shu
PYPengcheng Yang
Pengcheng Yang
XZXuezhong Zhou
Xuezhong Zhou
Objective: The recent surge in large language models (LLMs) across various fields has yet to be fully realized in traditional Chinese medicine (TCM). This study aims to bridge this gap by developing a large language model tailored to TCM knowledge, enhancing its performance and accuracy in clinical reasoning tasks such as diagnosis, treatment, and prescription recommendations. Materials and Methods: This study harnessed a wide array of TCM data resources, including TCM ancient books, textbooks, and clinical data, to create 3 key datasets: the TCM Pre-trained Dataset, the Traditional Chinese Patent Medicine (TCPM) Question Answering Dataset, and the Spleen and Stomach Herbal Prescription Recommendation Dataset. These datasets underpinned the development of the Lingdan Pre-trained LLM and 2 specialized models: the Lingdan-TCPM-Chat Model, which uses a Chain-of-Thought process for symptom analysis and TCPM recommendation, and a Lingdan Prescription Recommendation model (Lingdan-PR) that proposes herbal prescriptions based on electronic medical records. Results: The Lingdan-TCPM-Chat and the Lingdan-PR Model, fine-tuned on the Lingdan Pre-trained LLM, demonstrated state-of-the art performances for the tasks of TCM clinical knowledge answering and herbal prescription recommendation. Notably, Lingdan-PR outperformed all state-of-the-art baseline models, achieving an improvement of 18.39% in the Top@20 F1-score compared with the best baseline. Conclusion: This study marks a pivotal step in merging advanced LLMs with TCM, showcasing the potential of artificial intelligence to help improve clinical decision-making of medical diagnostics and treatment strategies. The success of the Lingdan Pre-trained LLM and its derivative models, Lingdan-TCPM-Chat and Lingdan-PR, not only revolutionizes TCM practices but also opens new avenues for the application of artificial intelligence in other specialized medical fields. Our project is available at https://github.com/TCMAI-BJTU/LingdanLLM.

10 April 2024 in Journal of the American Medical Informatics Association
Verified
Journal Article
Closed access
PDF file
XDXin Dong
Xin Dong
CZChenxi Zhao
Chenxi Zhao
XSXinpeng Song
Xinpeng Song
LZLei Zhang
Lei Zhang
YLYu Liu
Yu Liu
XZXuezhong Zhou
Xuezhong Zhou
Herbal prescription recommendation (HPR) is a hot topic and challenging issue in field of clinical decision support of traditional Chinese medicine (TCM). However, almost all previous HPR methods have not adhered to the clinical principles of syndrome differentiation and treatment planning of TCM, which has resulted in suboptimal performance and difficulties in application to real-world clinical scenarios. We emphasize the synergy among diagnosis and treatment procedure in real-world TCM clinical settings to propose the PresRecST model, which effectively combines the key components of symptom collection, syndrome differentiation, treatment method determination, and herb recommendation. This model integrates a self-curated TCM knowledge graph to learn the high-quality representations of TCM biomedical entities and performs 3 stages of clinical predictions to meet the principle of systematic sequential procedure of TCM decision making. To address the limitations of previous datasets, we constructed the TCM-Lung dataset, which is suitable for the simultaneous training of the syndrome differentiation, treatment method determination, and herb recommendation. Overall experimental results on 2 datasets demonstrate that the proposed PresRecST outperforms the state-of-the-art algorithm by significant improvements (eg, improvements of P@5 by 4.70%, P@10 by 5.37%, P@20 by 3.08% compared with the best baseline). The workflow of PresRecST effectively integrates the embedding vectors of the knowledge graph for progressive recommendation tasks, and it closely aligns with the actual diagnostic and treatment procedures followed by TCM doctors. A series of ablation experiments and case study show the availability and interpretability of PresRecST, indicating the proposed PresRecST can be beneficial for assisting the diagnosis and treatment in real-world TCM clinical settings. Our technology can be applied in a progressive recommendation scenario, providing recommendations for related items in a progressive manner, which can assist in providing more reliable diagnoses and herbal therapies for TCM clinical task.

1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XDXin Dong
Xin Dong
YZYi Zheng
Yi Zheng
ZSZixin Shu
Zixin Shu
KCKai Chang
Kai Chang
JXJianan Xia
Jianan Xia
XZXuezhong Zhou
Xuezhong Zhou
Traditional Chinese medicine (TCM) has played an indispensable role in clinical diagnosis and treatment. Based on a patient’s symptom phenotypes, computation‐based prescription recommendation methods can recommend personalized TCM prescription using machine learning and artificial intelligence technologies. However, owing to the complexity and individuation of a patient’s clinical phenotypes, current prescription recommendation methods cannot obtain good performance. Meanwhile, it is very difficult to conduct effective representation for unrecorded symptom terms in an existing knowledge base. In this study, we proposed a subnetwork‐based symptom term mapping method (SSTM) and constructed a SSTM‐based TCM prescription recommendation method (termed TCMPR). Our SSTM can extract the subnetwork structure between symptoms from a knowledge network to effectively represent the embedding features of clinical symptom terms (especially the unrecorded terms). The experimental results showed that our method performs better than state‐of‐the‐art methods. In addition, the comprehensive experiments of TCMPR with different hyperparameters (i.e., feature embedding, feature dimension, subnetwork filter threshold, and feature fusion) demonstrate that our method has high performance on TCM prescription recommendation and potentially promote clinical diagnosis and treatment of TCM precision medicine.

1 October 2024 in Phytomedicine
Verified
Journal Article
Closed access
KYKuo Yang
Kuo Yang
XDXin Dong
Xin Dong
SZShuhan Zhang
Shuhan Zhang
HYHaibin Yu
Haibin Yu
LZLiqun Zhong
Liqun Zhong
XZXuezhong Zhou
Xuezhong Zhou

14 May 2026
Verified
Open access
XTXinli Tao
Xinli Tao
XDXin Dong
Xin Dong
QZQiang Zhu
Qiang Zhu
XZXuezhong Zhou
Xuezhong Zhou
With the rapid growth of unstructured clinical narratives in electronic health records (EHRs), clinical named entity recognition (NER) has become a crucial technique for extracting structured medical information. However, traditional supervised models such as CRF and BioClinicalBERT rely on costly manual annotations. Although large language model (LLM)-based zero-shot NER reduces the dependency on labeled data, challenges remain in aligning example selection with task granularity and in effectively integrating prompt design with self-improvement frameworks. To address these limitations, we propose OEMA, a novel zero-shot clinical NER framework based on ontology-enhanced multi-agent collaboration. OEMA consists of three core components: (1) a self-annotator that autonomously generates candidate examples; (2) a discriminator that leverages SNOMED CT to filter token-level examples based on clinical relevance; and (3) a predictor that incorporates entity-type descriptions to enhance inference consistency and accuracy. Experimental results on three benchmark datasets, including the real-world I2B2 2010 dataset alongside MTSamples and VAERS, demonstrate that OEMA consistently outperforms existing zero-shot baselines under exact-match evaluation across multiple backbone LLMs (including gpt-3.5, gpt-4.1, and gemini-2.5-flash). Moreover, under relaxed-match criteria, OEMA performs comparably to the supervised BioClinicalBERT model while significantly outperforming the traditional CRF method. OEMA integrates ontology-guided reasoning with multi-agent collaboration to address two key challenges in zero-shot clinical NER: granularity mismatch and prompt-self-improvement integration. Ablation studies indicate that ontology-based filtering reduces noise and improves semantic alignment, helping to bridge the style gap between synthetic data and real-world clinical narratives. OEMA advances zero-shot clinical NER and achieves performance approaching supervised models under relaxed-match criteria. Future work will focus on continual learning, open-domain adaptation, negation and assertion status detection, and multilingual generalization to further expand its applicability in clinical NLP.

19 November 2024 in Bioinformatics
Verified
Journal Article
Open access
PDF file
SFShuyue Fan
Shuyue Fan
KYKuo Yang
Kuo Yang
KLKezhi Lu
Kezhi Lu
XDXin Dong
Xin Dong
XLXianan Li
Xianan Li
XZXuezhong Zhou
Xuezhong Zhou
Drug repositioning, identifying novel indications for approved drugs, is a cost-effective strategy in drug discovery. Despite numerous proposed drug repositioning models, integrating network-based features, differential gene expression, and chemical structures for high-performance drug repositioning remains challenging. We propose a comprehensive deep pre-training and fine-tuning framework for drug repositioning, termed DrugRepPT. Initially, we design a graph pre-training module employing model-augmented contrastive learning on a vast drug-disease heterogeneous graph to capture nuanced interactions and expression perturbations after intervention. Subsequently, we introduce a fine-tuning module leveraging a graph residual-like convolution network to elucidate intricate interactions between diseases and drugs. Moreover, a Bayesian multi-loss approach is introduced to balance the existence and effectiveness of drug treatment effectively. Extensive experiments showcase the efficacy of our framework, with DrugRepPT exhibiting remarkable performance improvements compared to SOTA baseline methods (Improvement 106.13% on Hit@1 and 54.45% on mean reciprocal rank). The reliability of predicted results is further validated through two case studies, ie, gastritis and fatty liver, via literature validation, network medicine analysis, and docking screening. The code and results are available at https://github.com/2020MEAI/DrugRepPT. Supplementary data are available at Bioinformatics online.